Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

More articles from Accelerated Communication

  • You have access
    HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE
    Hai-Zhi Bu, Ping Kang, Alan J. Deese, Ping Zhao and William F. Pool
    Drug Metabolism and Disposition December 2005, 33 (12) 1920-1924; DOI: https://doi.org/10.1124/dmd.105.006866
  • You have access
    QUANTITATIVE ANALYSIS OF CYTOCHROME P450 ISOZYMES BY MEANS OF UNIQUE ISOZYME-SPECIFIC TRYPTIC PEPTIDES: A PROTEOMIC APPROACH
    Michail A. Alterman, Boris Kornilayev, Tatyana Duzhak and Dmitry Yakovlev
    Drug Metabolism and Disposition September 2005, 33 (9) 1399-1407; DOI: https://doi.org/10.1124/dmd.105.004812
  • You have access
    A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
    Sean Ekins, Eugene Kirillov, Eugene A. Rakhmatulin and Tatiana Nikolskaya
    Drug Metabolism and Disposition March 2005, 33 (3) 474-481; DOI: https://doi.org/10.1124/dmd.104.002717
  • You have access
    KUPFFER CELL-MEDIATED IL-2 SUPPRESSION OF CYP3A ACTIVITY IN HUMAN HEPATOCYTES
    Jeffrey A. Sunman, Roy L. Hawke, Edward L. LeCluyse and Angela D. M. Kashuba
    Drug Metabolism and Disposition March 2004, 32 (3) 359-363; DOI: https://doi.org/10.1124/dmd.32.3.359
  • You have access
    A NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVES
    Charles W. Locuson, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock and Jeffrey P. Jones
    Drug Metabolism and Disposition July 2003, 31 (7) 967-971; DOI: https://doi.org/10.1124/dmd.31.7.967
  • You have access
    Induction of Cytochrome P450 3A by Paclitaxel in Mice: Pivotal Role of the Nuclear Xenobiotic Receptor, Pregnane X Receptor
    Srikanth C. Nallani, Bryan Goodwin, Jodi M. Maglich, Donna J. Buckley, Arthur R. Buckley and Pankaj B. Desai
    Drug Metabolism and Disposition May 2003, 31 (5) 681-684; DOI: https://doi.org/10.1124/dmd.31.5.681
  • You have access
    Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
    Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
    Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608
  • You have access
    A Pharmacophore for Human Pregnane X Receptor Ligands
    Sean Ekins and Jon A. Erickson
    Drug Metabolism and Disposition January 2002, 30 (1) 96-99; DOI: https://doi.org/10.1124/dmd.30.1.96
  • You have access
    Thalidomide Is Distributed into Human Semen after Oral Dosing
    Steve K. Teo, Jill L. Harden, Alison B. Burke, Faruq H. Noormohamed, Mike Youle, Margaret A. Johnson, Barry S. Peters, David I. Stirling and Steve D. Thomas
    Drug Metabolism and Disposition October 2001, 29 (10) 1355-1357;
  • You have access
    Electrophysiological Analysis of the Substrate Selectivity of a Sodium-Coupled Nucleoside Transporter (rCNT1) Expressed inXenopus laevis Oocytes
    Mark J. Dresser, Karin M. Gerstin, Andrew T. Gray, Donald D. F. Loo and Kathleen M. Giacomini
    Drug Metabolism and Disposition September 2000, 28 (9) 1135-1140;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics